Skip to main content

Table 1 Patient characteristics in 6 patients.

From: Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer

Case

Age

Sex

Time to LR (months)

Initial surgery

Recurrent site

ECOG PS

#1

54

Male

9

AR

Local

0

#2

55

Male

72

LAR

Local

0

#3

66

Male

65

AR

Local, lung

0

#4

62

Male

11

TPE

Local, lung

0

#5

50

Male

22

LAR

Local, lung

0

#6

56

Male

23

LAR

Local, liver, LN

0

  1. LR, local recurrence; ECOG, Eastern Cooperative Oncology Group; PS, performance status; AR, anterior resection; LAR, low anterior resection; TPE, total pelvic exenteration